Westminster, CO, United States of America

Manoj Vinayak Marathe

This inventor holds 3 USPTO granted patents. Top assignee: Cortech, Inc.. Active years: 1997-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manoj Vinayak Marathe. Retrieved from https://idiyas.com/inventor/manoj-vinayak-marathe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Pittsburgh, PA (US) (1997)
  • Westminster, CO (US) (1999 - 2000)

Company Filing History:


Years Active: 1997-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Manoj Vinayak Marathe

Introduction

Manoj Vinayak Marathe is an accomplished inventor based in Westminster, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bradykinin antagonists. With a total of three patents to his name, Marathe continues to push the boundaries of innovation in his industry.

Latest Patents

Marathe's latest patents include a bradykinin antagonist of a specific formula. This innovation aims to provide therapeutic benefits in various medical applications. His work in this area showcases his commitment to advancing healthcare solutions.

Career Highlights

Currently, Marathe is employed at Cortech, Inc., where he applies his expertise in drug development. His role at the company allows him to collaborate with other talented professionals in the field. His contributions have been instrumental in the progress of the company's research initiatives.

Collaborations

Some of his notable coworkers include Val S Goodfellow and Eric T Whalley. Their collaborative efforts have led to advancements in their respective projects, further enhancing the innovative environment at Cortech, Inc.

Conclusion

Manoj Vinayak Marathe is a notable inventor whose work in bradykinin antagonists has the potential to impact the pharmaceutical industry significantly. His dedication to innovation and collaboration continues to drive advancements in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…